# Natural Biocon (NSE: NATURAL) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/NATURAL · Pivot · prices to 19 Oct 2026

With a market capitalisation of ₹9 Cr, it ranks 3945th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Cement & Materials sector; its industry is Specialty Chemicals.

Its return on equity was 0.1% in FY25. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹1 Cr (−34.8% year on year) and net profit −₹0 Cr, on a standalone basis. Promoters held 9.36% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹9 Cr |
| ROE | 0.1% (FY25) |
| ROCE | 0.2% (FY25) |
| Debt to equity | 0.01 |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹1 Cr | −34.8% | −₹0 Cr | — | −₹0.04 |
| Q3 FY26 | — | — | −₹0 Cr | −116.0% | −₹0.02 |
| Q2 FY26 | — | — | −₹0 Cr | −120.0% | −₹0.02 |
| Q1 FY26 | ₹2 Cr | +68.7% | ₹0 Cr | +40.0% | ₹0.05 |
| Q4 FY25 | ₹1 Cr | −88.1% | −₹0 Cr | −916.7% | −₹0.19 |
| Q3 FY25 | ₹1 Cr | −40.7% | ₹0 Cr | +212.5% | ₹0.10 |
| Q2 FY25 | ₹5 Cr | +46.3% | ₹0 Cr | +42.9% | ₹0.08 |
| Q1 FY25 | ₹1 Cr | +266.7% | ₹0 Cr | +100.0% | ₹0.01 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹8 Cr | ₹0 Cr |
| FY24 | ₹14 Cr | ₹0 Cr |
| FY23 | ₹1 Cr | ₹0 Cr |
| FY22 | ₹0 Cr | ₹0 Cr |
| FY21 | ₹0 Cr | ₹0 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 9.36%
- Non-institutions: 90.64%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Aadi Industries](https://app.pivotnow.in/stock/AADIIND) | — | ₹9 Cr | — | — |
| [Ashish Polyplas](https://app.pivotnow.in/stock/ASHISHPO) | — | ₹9 Cr | — | — |
| [Arcee Ind](https://app.pivotnow.in/stock/ARCEEIN) | — | ₹8 Cr | — | — |
| [Dhyaani Trade](https://app.pivotnow.in/stock/DHYAANITR) | — | ₹8 Cr | — | — |
| [Mayur Floorings](https://app.pivotnow.in/stock/MAYURFL) | — | ₹8 Cr | — | — |
| [MONIND](https://app.pivotnow.in/stock/MONIND) | — | ₹8 Cr | — | — |

## Questions and answers

### What is the market cap of Natural Biocon?

Natural Biocon's market capitalisation is ₹9 Cr (₹9 Cr) at the 19 Oct 2026 close, ranking 3945th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Natural Biocon?

Return on equity was 0.1% in FY25 and return on capital employed was 0.2% in FY25 (standalone figures).

### Is Natural Biocon a debt-free company?

Natural Biocon is close to debt-free: its debt-to-equity ratio was 0.01 in FY25.

### What were Natural Biocon's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Natural Biocon reported revenue of ₹1 Cr, −34.8% year on year, and net profit of −₹0 Cr.

### What is the shareholding pattern of Natural Biocon?

As of 30 Jun 2026: promoters 9.36%, non-institutions 90.64%.

### Who are Natural Biocon's competitors?

The listed Cement & Materials companies closest to Natural Biocon by market cap are Aadi Industries, Ashish Polyplas, Arcee Ind, Dhyaani Trade, Mayur Floorings and MONIND.

### Is Natural Biocon a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Natural Biocon's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on NATURAL against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.